Personal Genome Diagnostics raises $65 million in ongoing financing round - Baltimore Sun

Personal Genome Diagnostics, a Baltimore-based cancer diagnostics company, said in a regulatory filing it has raised $65 million in an ongoing equity financing round in which it hopes to raise $111.5 million.